Derek had eight months of contracting experience and a strong set of year-over-year savings numbers when he stood up in front of the medical executive committee to present his team's managed care results. He opened with the framing he'd used in every internal meeting that quarter: "Our job is to control what we spend on care." Halfway through his second slide, the chief of surgery cut him off. "So when you say control spending, are you telling this committee that keeping my patients healthy is secondary to your budget?" The room went quiet. Derek hadn't said anything false. He'd just said something incomplete, and in that room, incomplete sounded like a confession.
He spent the rest of the meeting playing defense on a point he actually agreed with.
The gap that isn't in the numbers
Managed care gets reduced to a cost story more often than it should, and usually by the people whose job is to defend it. That's an easy trap, because cost containment is the part of the job that shows up in a spreadsheet and gets asked about most in an executive meeting. It's also only one of three things managed care is actually built to do, and leaving the other two out of the room is exactly what turns a clinical leader into an adversary instead of a partner.
The external problem is that managed care genuinely is complicated, spanning contract negotiation, claims administration, quality reporting, and regulatory compliance all at once, and no single term captures that. But the internal problem, the one Derek ran into, is more specific: when the people representing managed care internally talk about it as pure cost control, they hand every clinical stakeholder in the room a reason to distrust them. Nobody wants to hear that their patients' care is being run through a budget exercise, even when that's not actually what's happening.
I've been doing this work since 1992, and the negotiators and analysts who earn trust fastest, from physicians, health plan sponsors, and plan members alike, are the ones who can explain what managed care is actually built to balance, not just what it's built to save.
The three fundamentals worth reiterating here
Managed care rests on three tenets, and all three need to be in the room together, every time.
Cost containment is the discipline of negotiating contracts that align payer and provider incentives so that high-quality care stays financially sustainable for everyone delivering it. It's real, and it's necessary, but it's not the whole story.
Utilization management exists to get the right care, at the right time, in the right setting, catching both under-treatment and over-treatment before either one hurts the patient or the system. This is the piece that gets left out of the cost conversation most often, and it's the one that actually protects clinical judgment instead of overriding it.
Quality assurance is the non-negotiable third leg. Managed care stakeholders monitor and evaluate the care being delivered specifically so cost discipline never comes at the expense of the outcome the patient actually needs. Leave this out of the framing and every cost conversation sounds like a threat to the thing it's supposed to protect.
Say all three in the same breath, every time, and the room stops hearing a budget pitch. They hear the actual system they're part of.
What changes when you lead with all three
Lead with cost alone, and you'll spend every meeting rebuilding trust you didn't need to lose. That's what cost Derek the rest of his presentation, a room full of clinical leaders who now assumed his numbers were the whole agenda instead of one piece of it.
Derek rebuilt his next presentation around all three tenets before he opened with a single savings figure. He started with utilization management data showing where the right care had been delivered in the right setting, moved to quality outcomes tied to that care, and closed with the cost impact as the result of getting the first two right, not the goal that drove them. The same chief of surgery asked two clarifying questions and signed off on the next quarter's targets before the meeting ended.
Before your next stakeholder conversation about managed care, write out all three tenets and check that your talking points actually cover all of them, not just the one that's easiest to measure.
Managed care has been evolving since long before either of us got into this field, and it'll keep evolving. The fundamentals underneath it haven't changed since 1992, and neither has the cost of leaving two-thirds of them out of the room.
Call to Action: If you've ever had a managed care conversation go sideways because cost was the only thing on the table, tell me what happened in the comments. I want to hear how you got the room back.
Send this to whoever on your team is presenting managed care results to clinical leadership next.
About the Author: Kevin W. Barron, MBA, FHFMA, FACHE is a nationally recognized healthcare contracting and payer relations executive with over 30 years of experience in healthcare finance. He is an author, speaker, and mentor to emerging leaders in healthcare finance. Follow Kevin on LinkedIn or subscribe to his weekly newsletter at https://www.KevinWatsonBarron.com
Disclaimer: This article is provided for general informational and educational purposes only. It reflects my personal views and observations based on professional experience in healthcare finance, managed care, payer relations, and revenue cycle operations. It should not be interpreted as legal, financial, regulatory, actuarial, or reimbursement advice. The content is not intended to represent the official position of my employer, any payer, provider, professional association, or other organization with which I may be affiliated. Readers should consult their own legal, financial, compliance, actuarial, or operational advisors before making decisions based on the issues discussed. Any references to payers, providers, regulations, market trends, or reimbursement practices are intended for discussion and education only and should not be construed as a statement about any specific contract, negotiation, patient matter, or confidential business arrangement.